c1 esterase inhibitor recombinant
c1 esterase inhibitor recombinant is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Ruconest. Available dosage form: injection, powder, for solution.
Drug Details
- Generic Name
- c1 esterase inhibitor recombinant
- Brand Names
- Ruconest
- Application Number
- BLA125495
- Sponsor
- Pharming Healthcare Inc.
- NDC Codes
- 1
- Dosage Forms
- INJECTION, POWDER, FOR SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- CONESTAT ALFA
Indications and Usage
1 INDICATIONS AND USAGE RUCONEST is a C1 esterase inhibitor [recombinant] indicated for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE). Limitation of Use: Effectiveness was not established in HAE patients with laryngeal attacks. RUCONEST is a C1 esterase inhibitor [recombinant] indicated for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE). ( 1 ) Limitation of Use: Effectiveness was not established in HAE patients with laryngeal attacks.